Marusyk Andriy, Wheeler Linda J, Mathews Christopher K, DeGregori James
Department of Biochemistry and Molecular Genetics, Program in Molecular Biology, University of Colorado at Denver Health Sciences Center, Aurora, CO 80045, USA.
Mol Cell Biol. 2007 Aug;27(15):5336-51. doi: 10.1128/MCB.01316-06. Epub 2007 May 21.
Previous studies have shown that exposure of cells to high levels of replicational stress leads to permanent proliferation arrest that does not require p53. We have examined cellular responses to therapeutically relevant low levels of replicational stress that allow limited proliferation. Chronic exposure to low concentrations of hydroxyurea, aphidicolin, or etoposide induced irreversible cell cycle arrest after several population doublings. Inhibition of p53 activity antagonized this arrest and enhanced the long-term proliferation of p53 mutant cells. p21CIP1 was found to be a critical p53 target for arrest induced by hydroxyurea or aphidicolin, but not etoposide, as judged by the ability of p21CIP1 suppression to mimic the effects of p53 disruption. Suppression of Rad51 expression, required for homologous recombination repair, blocked the ability of mutant p53 to antagonize arrest induced by etoposide, but not aphidicolin. Thus, the ability of mutant p53 to prevent arrest induced by replicational stress per se is primarily dependent on preventing p21CIP1 up-regulation. However, when replication stress is associated with DNA strand breaks (such as with etoposide), up-regulation of homologous recombination repair in response to p53 disruption becomes important. Since replicational stress leads to clonal selection of cells with p53 mutations, our results highlight the potential importance of chronic replicational stress in promoting cancer development.
先前的研究表明,将细胞暴露于高水平的复制应激会导致永久性增殖停滞,且这一过程并不需要p53的参与。我们已经研究了细胞对治疗相关的低水平复制应激(允许有限增殖)的反应。长期暴露于低浓度的羟基脲、阿非迪霉素或依托泊苷会在几次群体倍增后诱导不可逆的细胞周期停滞。抑制p53活性可对抗这种停滞,并增强p53突变细胞的长期增殖。p21CIP1被发现是羟基脲或阿非迪霉素诱导停滞的关键p53靶点,但不是依托泊苷诱导停滞的关键靶点,这是根据p21CIP1抑制模拟p53破坏效应的能力来判断的。抑制同源重组修复所需的Rad51表达,会阻断突变型p53对抗依托泊苷诱导停滞的能力,但不会阻断其对抗阿非迪霉素诱导停滞的能力。因此,突变型p53防止复制应激本身诱导停滞的能力主要取决于防止p21CIP1上调。然而,当复制应激与DNA链断裂相关(如依托泊苷)时,响应p53破坏而进行的同源重组修复上调就变得很重要。由于复制应激会导致具有p53突变的细胞发生克隆选择,我们的结果凸显了慢性复制应激在促进癌症发展中的潜在重要性。